HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP

Overview Fund Activity
Delisted

HZNP was delisted on the 5th of October, 2023.

Back to rankings

177 hedge funds and large institutions have $2.57B invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2015 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 56 increasing their positions, 43 reducing their positions, and 25 closing their positions.

Holders
177
Holders Change
+41
Holders Change %
+30.15%
% of All Funds
4.72%
Holding in Top 10
15
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+87.5%
% of All Funds
0.4%
New
66
Increased
56
Reduced
43
Closed
25
Calls
$96.7M
Puts
$23.1M
Net Calls
+$73.6M
Net Calls Change
+$51.4M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$226M
2
LCM
2
LionEye Capital Management
New York
$48.9M
3
CIP
3
Chartwell Investment Partners
Pennsylvania
$44.4M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$143M
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$37.8M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$6.07M
2
KCM
2
Kingdon Capital Management
New York
$96M
3
BC
3
Broadfin Capital
New York
$183M
4
HM
4
HealthCor Management
New York
$104M
5
VAM
5
Visium Asset Management
New York
$76.9M
Name Market Value Shares Shares
Change 		Shares
Change %
DM
1
Deerfield Management
New York
$332M 12,792,689 +1,093,642 +9%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$226M 8,709,848 +2,638,452 +43%
BC
3
Broadfin Capital
New York
$183M 7,053,504 -1,864,471 -21%
Vanguard Group
4
Vanguard Group
Pennsylvania
$143M 5,506,926 +1,502,079 +38%
HM
5
HealthCor Management
New York
$104M 4,000,000 -1,600,000 -29%
KCM
6
Kingdon Capital Management
New York
$96M 3,697,140 -2,377,476 -39%
VAM
7
Visium Asset Management
New York
$76.9M 2,960,546 -1,531,978 -34%
State Street
8
State Street
Massachusetts
$70.3M 2,705,746 -764,667 -22%
TCP
9
Tourbillon Capital Partners
New York
$69.2M 2,665,000 +1,415,000 +113%
TCM
10
TimesSquare Capital Management
New York
$54.9M 2,115,500 -468,500 -18%
LCM
11
LionEye Capital Management
New York
$48.9M 1,882,000 +1,882,000 New
Bank of New York Mellon
12
Bank of New York Mellon
New York
$48.4M 1,863,108 +750,415 +67%
SM
13
Scale Management
California
$44.4M 1,710,451 -494,112 -22%
CIP
14
Chartwell Investment Partners
Pennsylvania
$44.4M 1,708,880 +1,708,880 New
HCM
15
Hodges Capital Management
Texas
$40.6M 1,562,904 -117,140 -7%
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$40.4M 1,557,023 +149,719 +11%
CM
17
Castleark Management
Illinois
$39.5M 1,519,050 +917,550 +153%
JPMorgan Chase & Co
18
JPMorgan Chase & Co
New York
$37.8M 1,454,777 +1,443,907 +13,283%
KCM
19
Kennedy Capital Management
Missouri
$37.4M 1,441,949 +1,441,949 New
Lord, Abbett & Co
20
Lord, Abbett & Co
New Jersey
$29.2M 1,124,104 +1,124,104 New
BPCM
21
Beach Point Capital Management
California
$29M 1,118,518 +1,118,518 New
O
22
OrbiMed
New York
$27.9M 1,075,000 – –
GT
23
Glenmede Trust
Pennsylvania
$27.4M 1,054,141 +1,054,141 New
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
$23.3M 895,494 -665,866 -43%
T. Rowe Price Associates
25
T. Rowe Price Associates
Maryland
$22.4M 862,000 -4,700 -0.5%
1
2 3 4 5